angiotensin ii has been researched along with Hyperplasia in 129 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 40 (31.01) | 18.7374 |
1990's | 32 (24.81) | 18.2507 |
2000's | 35 (27.13) | 29.6817 |
2010's | 20 (15.50) | 24.3611 |
2020's | 2 (1.55) | 2.80 |
Authors | Studies |
---|---|
He, Y; Teng, S; Wu, C; Zhou, S; Zhu, Z | 1 |
Aburel, OM; Angoulvant, D; Benoist, L; Chadet, S; Gabillard-Lefort, C; Ivanes, F; Muntean, DM; Piollet, M; Sturza, A | 1 |
Alajbegovic, A; Albinsson, S; Bhattachariya, A; Boettger, T; Braun, T; Dahan, D; Ekman, M; Hellstrand, P; Hien, TT; Holmberg, J; Rippe, C; Swärd, K | 1 |
Dai, Y; Dong, Y; Li, Z; Xiong, Y; Xu, C; Yan, Z | 1 |
Cheng, C; Huang, Q; Lin, X; Liu, B; Liu, S; Luo, C; Mo, P; Ou, W; Zhong, J | 1 |
Dong, H; Fang, J; Li, Y; Liu, L; Ming, S | 1 |
Sun, Y; Wen, JK; Wen, Y; Zhang, XH; Zhao, XS; Zheng, B | 1 |
Bourne, AM; Eguchi, A; Eguchi, S; Elliott, KJ; Hinoki, A; Hurlin, PJ; Takaguri, A; Takayanagi, T | 1 |
Chen, J; Hu, X; Jiang, H; Lu, Z; Xu, C; Zhang, J; Zhou, X | 1 |
Sadoshima, J; Zablocki, D | 1 |
Chen, J; Ding, J; Guo, Q; Hu, Q; Jiang, H; Xu, C; Yang, J; Zhang, J | 1 |
Afroze, SH; Dostal, D; Gergely, M; Glaser, S; Guerrier, M; Martínez, AK; Munshi, MK; Nizamutdinov, D; Szynkarski, C; Uddin, M | 1 |
He, H; He, J; He, L; Wang, T; Zhang, Y; Zhou, N | 1 |
Sandgren, J; Scholz, TD; Segar, JL | 1 |
Balakrishnan, A; Cassis, LA; Daugherty, A; Howatt, DA; Moorleghen, JJ; Poduri, A; Rateri, DL | 1 |
Aoka, Y; Hagiwara, N; Kasanuki, H; Kawana, M; Nagashima, H; Sakurabayashi-Kitade, S | 1 |
Cho, WH; Choi, HS; Hur, SH; Jung, GS; Kim, BW; Kim, HS; Kim, HT; Kim, JG; Kim, MK; Lee, HJ; Lee, IK; Lee, KM; Lee, KU; Lim, JO; Park, KG | 1 |
Aizawa, Y; Azuma, J; Doi, T; Iekushi, K; Koibuchi, N; Kusunoki, H; Morishita, R; Okayama, K; Sanada, F; Taniyama, Y | 1 |
Cassis, LA; Daugherty, A; Guo, Z; McNamara, CA; Moorleghen, JJ; Owens, AP; Subramanian, V | 1 |
Anand-Srivastava, MB; Lévesque, LO; Li, Y | 1 |
Tian, ZJ | 1 |
Bortz, PD; Halterman, JA; Kwon, HM; Wamhoff, BR; Zargham, R | 1 |
Chandrasekar, B; Clark, RA; Delafontaine, P; Katsuyama, M; Murthy, SN; Sakamuri, SS; Valente, AJ; Yoshida, T | 1 |
Dong, LH; Gao, M; Han, M; Liu, G; Lv, P; Miao, SB; Shu, YN; Wang, XJ; Wang, YC; Xie, XL; Yin, YJ | 1 |
Chen, J; Chen, S; Jiang, H; Xu, C; Xu, L; Yang, J; Zhang, J | 1 |
Asano, T; Fujita, T; Gao, J; Hasegawa, Y; Imai, J; Ishigaki, Y; Kaneko, K; Katagiri, H; Ogihara, T; Oka, Y; Saito, T; Shimosawa, T; Uno, K; Yamada, T | 1 |
Asada, K; Jin, D; Kondo, K; Miyazaki, M; Nishimoto, M; Sakaguchi, M; Sasaki, S; Sawada, Y; Takai, S; Tsunemi, K; Yuda, A | 1 |
Giraud, GD; Maylie, JG; Stork, PJ; Sundgren, NC; Thornburg, KL | 1 |
Baldi, A; Becu-Villalobos, D; Díaz-Torga, G; Gonzalez-Iglesias, A; Mladovan, A; Suárez, C; Vela, J | 1 |
Padfield, PL | 1 |
Gerzanich, V; Ivanova, S; Simard, JM | 1 |
Fujita, T; Goto, A; Hirata, Y; Nagai, R; Nishimatsu, H; Oba, S; Omata, M; Satonaka, H; Suzuki, E; Takeda, R | 1 |
Aartsen, WM; De Mey, JG; Fazzi, GE; Hilgers, RH; Schiffers, PM; Smits, JF | 1 |
Arima, N; Fujii, T; Imaizumi, T; Kato, S; Morimatsu, M; Okamoto, K | 1 |
Brimioulle, S; Fesler, P; Hubloue, I; Kerbaul, F; Ketelslegers, JM; Motte, S; Naeije, R; Remmelink, M; Rondelet, B; Salmon, I; Van Beneden, R | 1 |
Duan, ZQ; Feng, ZC; Gu, J; Sun, CL; Xin, SJ; Zhang, JH; Zhang, Q | 1 |
Choi, SY; Ishibashi, N; Jung, SI; Kim, JM; Kim, SJ; Kim, YS; Koo, BH; Lee, JB; Min, BW; Shirouzu, K; Son, GS; Um, JW; Whang, CW | 1 |
Jin, D; Katsuoka, Y; Miyazaki, M; Muramatsu, M; Okamoto, Y; Sakaguchi, M; Shibahara, N; Takai, S; Ueda, H | 1 |
Imai, T; Katayama, S; Morita, T; Sugiyama, T; Yoshino, G | 1 |
da Cunha, V; Martin-McNulty, B; Rutledge, JC; Sullivan, ME; Vergona, R; Vincelette, J; Wang, YX; Wilson, DW; Zhang, L | 1 |
Cheng, C; Daemen, MJ; de Crom, R; Grosveld, F; Krams, R; Tempel, D; van der Baan, A; van Haperen, R | 1 |
Bafford, R; Conte, M; Sui, XX; Wang, G | 1 |
Alonso, M; Suri, D; Weiss, RE | 1 |
Chaqour, B; Chung, JW; Kim, HS; Kim, JY; Koo, BK; Lee, HY; Oh, BH; Park, KW; Park, YB; Walsh, K; Youn, SW | 1 |
Bennett, MR; Littlewood, TD | 1 |
Bi, Y; Li, Y; Wang, B; Zhou, C | 1 |
Buikema, H; de Smet, BJ; Groenewegen, HC; Roks, AJ; van der Harst, P; van Gilst, WH; Zijlstra, F | 1 |
Ferrario, CM; Igase, M; Kohara, K; Miki, T; Nagai, T | 1 |
Becker, CH; Engler, E; Matthias, D; Schmidt, R | 1 |
Bourke, E; Delaney, V | 1 |
Kunert-Radek, J; Mucha, S; Pawlikowski, M; Pisarek, H; Sepien, H; Stawowy, A | 1 |
Fukuo, K; Inoue, T; Jiang, B; Koh, E; Morimoto, S; Nabata, T; Ogihara, T; Rakugi, H; Tomita, J | 1 |
Erdjument-Bromage, H; Marks, AR; Patton, WF; Taubman, MB; Tempst, P | 1 |
Fish, AF | 1 |
Eydelloth, RS; Hubert, MF; Keenan, KP; Molon-Noblot, S; Owen, RA; Siegl, PK | 1 |
Batlle, DC; LaPointe, MS | 1 |
Chiavegato, A; Faggin, E; Fulgeri, PD; Giuriato, L; Grisenti, A; Paci, MV; Pauletto, P; Rappelli, A; Sarzani, R; Scatena, M | 1 |
Izumo, S; Sadoshima, J | 1 |
Gibbons, GH; Koibuchi, Y; Lee, WS; Pratt, RE | 1 |
Furukawa, Y; Hirozane, T; Matsumori, A; Sasayama, S | 1 |
Barber, L; Dalen, H; Davies, MG; Fulton, GJ; Hagen, PO; Svendsen, E | 1 |
Rosendorff, C | 1 |
Egido, J; Ruiz-Ortega, M | 1 |
Azuma, J; Azuma, M; Baba, A; Schaffer, SW; Taira, K; Takahashi, K; Yamamoto, I | 1 |
Achával-Zaia, R; Becú-Villalobos, D; Díaz-Torga, G; González Iglesias, A; Libertun, C | 1 |
de Jongste, JC; McKay, S; Saxena, PR; Sharma, HS | 1 |
Lombardi, DM; Schwartz, SM; Siegal, J; Su, EJ | 1 |
Rao, GN | 1 |
Fukuda, N; Hu, WY; Izumi, Y; Kanmatsuse, K; Kishioka, H; Kubo, A; Satoh, C; Soma, M; Watanabe, Y | 1 |
Kimura, R; Matsuura, N; Miyake, H; Nozawa, Y; Yamada, S | 1 |
Becu-Villalobos, D; Diaz-Torga, G; Iglesias, AG; Libertun, C; Lux-Lantos, V | 1 |
Hong, KP; Huh, JE; Kim, DK; Lee, SH; Lee, WR; Park, JE; Seo, JD | 1 |
Fu, M; Liu, N; Pang, Y; Su, J; Tang, C; Xu, S; Zhang, J | 1 |
Achával-Zaia, R; Becu-Villalobos, D; De Nicola, AF; Díaz-Torga, G; González Iglesias, A; Libertun, C; Piroli, G | 1 |
Asada, K; Jin, D; Kondo, K; Matsuyama, N; Miyazaki, M; Nishimoto, M; Sasaki, S; Sawada, Y; Takai, S; Yuda, A | 1 |
Joles, JA; Klok, PA; Kuipers, F; Navis, G; Smit-van Oosten, A; Stegeman, CA; Tiebosch, AT; van Goor, H | 1 |
Kohno, Y; Koshiyama, H; Kuwamura, N; Matsuda, T; Nakamura, Y; Sasano, H; Shimono, D; Son, Y | 1 |
Bullock, GR; De Paepe, B; De Potter, CR; Vakaet, LA; Verstraeten, VL | 1 |
Liu, Y; Wang, M; Xu, D | 1 |
Benter, IF; Estes, A; Gaber, L; Karzoun, NA; Khandekar, Z; Ljuca, F; Malik, KU; Muthalif, MM; Uddin, MR | 1 |
Wang, HJ; Yao, T; Zhu, YC | 1 |
Du, J; Fujisawa, G; Fujita, N; Furukawa, Y; Ishibashi, S; Itabashi, N; Okada, K; Saito, T | 1 |
Ball, SG; Lee, MR; Thomas, RD | 1 |
Bartter, FC; Frolich, JC; Gill, JR | 1 |
Armanini, D; Boscaro, M; Mantero, F | 1 |
Bönner, G; Helber, A; Hummerich, W; Meurer, KA; Moritz, G | 1 |
Batolo, D; Demetrio, G; Di Pentima, G; Martines, F | 1 |
Janiak, P; Pillon, A; Prost, JF; Vilaine, JP | 1 |
Colyvas, N; Nelken, N; Pan, XM; Rapp, JH | 1 |
Dzau, VJ; Gibbons, GH; Pratt, RE | 2 |
Horikoshi, S; Klotman, PE; Kopp, JB; McCune, BK; Ray, PE; Sporn, MB | 1 |
Chouman, M; Fallo, F; Pagotto, U; Pistorello, M | 1 |
Berk, BC; Pouysségur, J; Rao, GN; Sardet, C | 1 |
Berk, BC; Elder, E; Mitsuka, M | 1 |
Bobrowski, WF; Dominick, MA; Gough, AW; MacDonald, JR; Metz, AL | 1 |
Bogyo, A; Duclos, JM; Girard, F; Leneuve, P; Pagny, JY; Pham-Huu-Trung, MT | 1 |
Hashimoto, K; Hattori, T; Hayata, S; Kageyama, J; Kawada, Y; Murakami, K; Ohashi, T; Omori, H; Ota, Z; Suemaru, S | 1 |
Pasternack, A | 1 |
Hänze, S; Pierach, CA; Stark, G | 1 |
Beilin, LJ; Crane, M; Nelson, DH; Schiffman, N | 1 |
Brackett, NC; Koppel, M; Nixon, WP; Randall, RE | 1 |
Gross, F | 1 |
Borzone, RJ; Márquez, FJ; Trabucco, AE | 1 |
Imai, M; Murata, H; Ohbe, Y; Sokabe, H; Takita, S; Yabuta, K | 1 |
Geelhoed, GW; Kelsch, RC; Oliver, WJ; Vander, AJ | 1 |
Kaufmann, W | 1 |
Endo, J; Kono, T; Tanaka, S; Yamashiki, Y; Yoshino, K | 1 |
Bloodworth, JM; Lobeck, CC; Mangos, JA; Trygstad, CW | 1 |
Goodman, AD; Hartroft, PM; Vagnucci, AH | 1 |
Bartter, FC | 1 |
Ancona, E; Borsatti, A; Corsini, A; Lechi, A; Oselladore, D; Spina, GS | 1 |
Bailey, JD; Balis, JU; Hartroft, P; Lynch, MJ; Sutherland, LE | 1 |
Brown, JJ; Cost, WS; Desmit, EM; Fraser, R; Lever, AF; Robertson, JI | 1 |
Arant, BS; Brackett, NC; Still, WJ; Young, RB | 1 |
Aso, Y; Kawabe, K; Nakauchi, K; Takayasu, H | 1 |
Biglieri, EG; Collins, RD; Stockigt, JR | 1 |
Pulver, W; Schmid, HJ | 1 |
White, MG | 1 |
Burmeister, H; Ruiz-Torres, A | 1 |
Kuhlmann, U; Schweikert, HU; Siegenthaler, W; Stadelmann, O; Stiel, D; Trübestein, GK; Werning, C | 1 |
Broyer, M; Godard, C; Royer, P; Vallotton, MB | 1 |
Herman, RH; Katz, FH; Lufkin, EG | 1 |
Benderli, A; Better, OS; Chaimovitz, C; Levi, J; Oslander, L | 1 |
Gantt, C; Grossman, A; Ramanathan, K | 1 |
Gabrilove, JL; Krakoff, LR; Modlinger, RS; Nicolis, GL | 1 |
Erkelens, DW; Statius van Eps, LW | 1 |
Horton, R | 1 |
Börner, H | 1 |
10 review(s) available for angiotensin ii and Hyperplasia
Article | Year |
---|---|
Bartter's syndrome - a dilemma of cause and effect.
Topics: Angiotensin II; Bartter Syndrome; Humans; Hyperaldosteronism; Hyperplasia; Hypokalemia; Juxtaglomerular Apparatus; Kallikreins; Kinins; Nephrons; Prostaglandins; Sodium Chloride | 1981 |
Angiotensin converting enzyme inhibitors: inhibition of growth, a novel mechanism of action.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Coronary Disease; Heart; Humans; Hyperplasia; Hypertension; Muscle Development; Muscle, Smooth, Vascular; Tunica Intima | 1994 |
Na+/H+ exchange and vascular smooth muscle proliferation.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Cell Division; Humans; Hydrogen-Ion Concentration; Hyperplasia; Muscle, Smooth, Vascular; Sodium-Hydrogen Exchangers | 1994 |
The renin-angiotensin system and vascular hypertrophy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Hyperplasia; Hypertrophy; Muscle, Smooth, Vascular; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction | 1996 |
Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Cell Division; Endothelium, Vascular; Humans; Hyperplasia; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Renin-Angiotensin System | 1991 |
["Hypertensive vascular changes" with and without hypertension].
Topics: Angiotensin II; Blood Vessels; Chronic Disease; Diarrhea; Female; Humans; Hyalin; Hyperaldosteronism; Hyperplasia; Hypertension; Hypertension, Malignant; Hypertrophy; Male; Necrosis; Nephrotic Syndrome; Renin; Vomiting | 1969 |
Control of aldosterone secretion by the renin-angiotensin system and by corticotropin.
Topics: Addison Disease; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertension; Hypopituitarism; Hypotension; In Vitro Techniques; Kidney Diseases; Pheochromocytoma; Pituitary Gland; Pituitary Hormones, Anterior; Potassium; Pregnancy; Renin; Serotonin; Sodium; Stress, Physiological; Stress, Psychological; Sympathetic Nervous System | 1968 |
[Renin-angiotensin-aldosterone system in blood pressure regulation disorders].
Topics: Adult; Aldosterone; Angiotensin II; Child; Electrolytes; Female; Humans; Hydrogen-Ion Concentration; Hyperaldosteronism; Hyperplasia; Hypertension; Juxtaglomerular Apparatus; Kidney; Male; Middle Aged; Pituitary-Adrenal System; Renal Artery Obstruction; Renin | 1968 |
Aldosterone: review of its physiology and diagnostic aspects of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Desoxycorticosterone; Humans; Hyperaldosteronism; Hyperplasia; Hypertension; Hypokalemia; Potassium; Radiography; Renin; Sodium; Spironolactone | 1973 |
[Renin-angiotensin-(aldosterone)-system-clinical aspects].
Topics: Acute Kidney Injury; Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Aldosterone; Angiotensin II; Desoxycorticosterone; Glycyrrhiza; Humans; Hyperaldosteronism; Hyperplasia; Hypertension; Hypertension, Renal; Kidney Neoplasms; Pheochromocytoma; Plants, Medicinal; Renin | 1973 |
119 other study(ies) available for angiotensin ii and Hyperplasia
Article | Year |
---|---|
Inflachromene inhibits intimal hyperplasia through the HMGB1/2- regulated TLR4-NF-κB pathway.
Topics: Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; HMGB1 Protein; HMGB2 Protein; Hyperplasia; Mice; Myocytes, Smooth Muscle; NF-kappa B; Toll-Like Receptor 4 | 2023 |
P2Y11 Agonism Prevents Hypoxia/Reoxygenation- and Angiotensin II-Induced Vascular Dysfunction and Intimal Hyperplasia Development.
Topics: Angiotensin II; Animals; Aorta; Diphosphonates; Endothelin-1; Human Umbilical Vein Endothelial Cells; Humans; Hyperplasia; Male; Myocytes, Smooth Muscle; Naphthalenesulfonates; Nitric Oxide; Nitric Oxide Synthase Type III; Purinergic P2 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P2; Reperfusion Injury; Tunica Intima; Vasodilation; Water | 2021 |
Loss of Vascular Myogenic Tone in miR-143/145 Knockout Mice Is Associated With Hypertension-Induced Vascular Lesions in Small Mesenteric Arteries.
Topics: Actin Cytoskeleton; Angiotensin II; Animals; Arterial Pressure; Calcium Signaling; Cells, Cultured; Disease Models, Animal; Elastic Tissue; Female; Fibrosis; Gene Knockout Techniques; Hyperplasia; Hypertension; Male; Mesenteric Arteries; Mice, Knockout; MicroRNAs; Muscle, Smooth, Vascular; Neointima; Vascular Remodeling; Vascular Resistance; Vasoconstriction | 2018 |
Acetylshikonin attenuates angiotensin II-induced proliferation and motility of human brain smooth muscle cells by inhibiting Wnt/β-catenin signaling.
Topics: Active Transport, Cell Nucleus; Angiotensin II; Anthraquinones; beta Catenin; Brain; Cell Cycle; Cell Movement; Cell Proliferation; Cells, Cultured; Cerebrovascular Disorders; Depression, Chemical; Drugs, Chinese Herbal; Glycogen Synthase Kinase 3 beta; Humans; Hyperplasia; Myocytes, Smooth Muscle; Phosphorylation; Phytotherapy; Stroke; Vascular Remodeling; Wnt Signaling Pathway | 2018 |
Resveratrol inhibits angiotensin II‑induced proliferation of A7r5 cells and decreases neointimal hyperplasia by inhibiting the CaMKII‑HDAC4 signaling pathway.
Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Cycle; Cell Line; Histone Deacetylases; Hyperplasia; Male; Neointima; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes | 2018 |
Icariin ameliorates angiotensin II-induced cerebrovascular remodeling by inhibiting Nox2-containing NADPH oxidase activation.
Topics: Angiotensin II; Animals; Basilar Artery; Brain; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Drugs, Chinese Herbal; Flavonoids; Humans; Hyperplasia; Hypertension; Muscle, Smooth, Vascular; NADPH Oxidase 2; NADPH Oxidases; Phytotherapy; Rats, Sprague-Dawley; Reactive Oxygen Species; Stroke; Vascular Remodeling | 2019 |
Salvianolic acid B inhibits Ang II-induced VSMC proliferation in vitro and intimal hyperplasia in vivo by downregulating miR-146a expression.
Topics: Angiotensin II; Animals; Benzofurans; Carotid Arteries; Cell Proliferation; Cells, Cultured; Down-Regulation; Gene Expression Regulation; Hyperplasia; Kruppel-Like Transcription Factors; Male; Mice, Inbred C57BL; MicroRNAs; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Tunica Intima | 2019 |
A repressor protein, Mnt, is a novel negative regulator of vascular smooth muscle cell hypertrophy by angiotensin II and neointimal hyperplasia by arterial injury.
Topics: Adenoviridae; Angioplasty, Balloon; Angiotensin II; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Carotid Artery Injuries; Green Fluorescent Proteins; Hyperplasia; Hypertrophy; Male; Muscle, Smooth, Vascular; Neointima; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Repressor Proteins; Signal Transduction; Transcription, Genetic | 2013 |
Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
Topics: Angiotensin II; Animals; Antioxidants; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Citrus; Coronary Restenosis; Dinoprost; Flavanones; Hyperplasia; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidative Stress; Phytotherapy; Plant Extracts; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Transcription Factor RelA; Tunica Intima | 2013 |
Solving the cardiac hypertrophy riddle: The angiotensin II-mechanical stress connection.
Topics: Angiotensin II; Animals; Cardiomegaly; Humans; Hyperplasia; Myocytes, Cardiac; Proto-Oncogene Proteins c-fos; Receptor, Angiotensin, Type 1; Signal Transduction; Stress, Mechanical | 2013 |
Sodium ferulate inhibits neointimal hyperplasia in rat balloon injury model.
Topics: Angioplasty, Balloon; Angiotensin II; Animals; Carotid Arteries; Carotid Artery Diseases; Cell Movement; Cell Proliferation; Cells, Cultured; Coumaric Acids; Drug Evaluation, Preclinical; Hyperplasia; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2014 |
Activation of the renin-angiotensin system stimulates biliary hyperplasia during cholestasis induced by extrahepatic bile duct ligation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Bile Ducts, Extrahepatic; Cell Line; Cell Proliferation; Cholestasis, Extrahepatic; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Hyperplasia; Ligation; Losartan; Male; Rats, Inbred F344; Renin-Angiotensin System; Signal Transduction | 2015 |
The imperatorin derivative OW1, a new vasoactive compound, inhibits VSMC proliferation and extracellular matrix hyperplasia.
Topics: Actins; Angiotensin II; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Calcium Channels; Cell Proliferation; Collagen Type I; Collagen Type III; Extracellular Matrix; Furocoumarins; Hyperplasia; Hypertension, Renovascular; Male; Matrix Metalloproteinases; Mesenteric Arteries; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley | 2015 |
ANG II modulation of cardiac growth and remodeling in immature fetal sheep.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Cardiomegaly; Cell Differentiation; Cell Enlargement; Cell Proliferation; Cell Size; Cyclin B1; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Fetal Heart; Gestational Age; Hyperplasia; Hypertension; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Nitroprusside; Proliferating Cell Nuclear Antigen; Sheep; Signal Transduction; Time Factors; Vasodilator Agents | 2015 |
Fibroblast Angiotensin II Type 1a Receptors Contribute to Angiotensin II-Induced Medial Hyperplasia in the Ascending Aorta.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Atherosclerosis; Disease Models, Animal; DNA; Fibroblasts; Gene Expression Regulation; Genotype; Hyperplasia; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Angiotensin, Type 1; RNA, Messenger; Tunica Media | 2015 |
Aldosterone blockade by Spironolactone improves the hypertensive vascular hypertrophy and remodeling in angiotensin II overproducing transgenic mice.
Topics: Aldosterone; Angiotensin II; Animals; Female; Hyperplasia; Hypertension; Hypertrophy; Male; Mice; Mice, Transgenic; Mineralocorticoid Receptor Antagonists; Osteopontin; Renin-Angiotensin System; Spironolactone; Tunica Intima | 2009 |
Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury.
Topics: Angioplasty, Balloon; Angiotensin II; Animals; Binding Sites; Blood Glucose; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Cells, Cultured; Cilostazol; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Fibrinolytic Agents; Hyperplasia; JNK Mitogen-Activated Protein Kinases; Male; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase Inhibitors; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad3 Protein; Tetrazoles; Transcriptional Activation; Transforming Growth Factor beta; Tunica Intima | 2009 |
Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Cell Proliferation; Cells, Cultured; ErbB Receptors; Heparin-binding EGF-like Growth Factor; Hepatocyte Growth Factor; Humans; Hyperplasia; Inflammation; Intercellular Signaling Peptides and Proteins; Ligands; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Phosphoric Monoester Hydrolases; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Reactive Oxygen Species; Receptors, Growth Factor; RNA Interference; Signal Transduction; Superoxide Dismutase; Time Factors; Transfection; Ubiquitination | 2009 |
Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Hyperplasia; Hypertension; Inhibitor of Differentiation Proteins; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Norepinephrine; Organ Specificity; Receptor, Angiotensin, Type 1; Renin; Tunica Media | 2010 |
Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Proliferation; Cells, Cultured; CSK Tyrosine-Protein Kinase; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Free Radical Scavengers; Hyperplasia; Hypertension; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidative Stress; Phosphorylation; Protein-Tyrosine Kinases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; src-Family Kinases; Superoxides | 2010 |
[Relation of intramyocardial collagen remodeling to the changes of myocardial systolic property and angiotensin II on the overtraining rats].
Topics: Angiotensin II; Animals; Collagen; Hyperplasia; Male; Myocardium; Myocytes, Cardiac; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Systole | 2002 |
Nuclear factor of activated T cells 5 regulates vascular smooth muscle cell phenotypic modulation.
Topics: Actins; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Becaplermin; Binding Sites; Carotid Artery Injuries; Cell Movement; Cell Proliferation; Cells, Cultured; Chromatin Immunoprecipitation; Coculture Techniques; Computational Biology; Disease Models, Animal; Gene Expression Regulation; Genes, Reporter; Humans; Hyperplasia; Introns; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NFATC Transcription Factors; Phenotype; Platelet-Derived Growth Factor; Promoter Regions, Genetic; Protein Transport; Proto-Oncogene Proteins c-sis; Rats; RNA Interference; RNA, Messenger; Transcription Factors; Transfection; Tunica Intima | 2011 |
Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Carotid Arteries; Cell Movement; Cell Proliferation; Cells, Cultured; Genes, Reporter; Hyperplasia; I-kappa B Kinase; Infusion Pumps, Implantable; Infusions, Subcutaneous; Interleukin-18; JNK Mitogen-Activated Protein Kinases; Losartan; Male; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Promoter Regions, Genetic; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; RNA Interference; Signal Transduction; Superoxides; Transcription Factor AP-1; Transcription Factor RelA; Transfection | 2012 |
Phosphorylation of smooth muscle 22α facilitates angiotensin II-induced ROS production via activation of the PKCδ-P47phox axis through release of PKCδ and actin dynamics and is associated with hypertrophy and hyperplasia of vascular smooth muscle cells in
Topics: Actins; Angiotensin II; Animals; Blotting, Western; Cells, Cultured; Down-Regulation; Enzyme Activation; Green Fluorescent Proteins; Humans; Hyperplasia; Hypertrophy; Male; Microfilament Proteins; Microscopy, Confocal; Muscle Proteins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Phosphorylation; Protein Binding; Protein Kinase C-delta; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA Interference | 2012 |
Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Cardiovascular Agents; Carotid Arteries; Carotid Artery Injuries; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Glycyrrhizic Acid; HMGB1 Protein; Hyperplasia; Inflammation Mediators; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phenotype; Rats; Rats, Sprague-Dawley; Receptors, Notch; Signal Transduction; Time Factors | 2012 |
Importance of endothelial NF-κB signalling in vascular remodelling and aortic aneurysm formation.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Biomarkers; Disease Models, Animal; Endothelium, Vascular; Femoral Artery; Humans; Hyperplasia; I-kappa B Proteins; Inflammation Mediators; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidative Stress; Signal Transduction; Vascular System Injuries | 2013 |
Lengthy suppression of vascular proliferation by a chymase inhibitor in dog grafted veins.
Topics: Angiotensin II; Animals; Chymases; Coronary Artery Bypass; Disease Models, Animal; Dogs; Femoral Vein; Hyperplasia; Japan; Models, Cardiovascular; Oligopeptides; Peptidyl-Dipeptidase A; Serine Endopeptidases; Treatment Outcome; Tunica Intima | 2002 |
Angiotensin II stimulates hyperplasia but not hypertrophy in immature ovine cardiomyocytes.
Topics: Angiotensin II; Animals; Bromodeoxyuridine; Cell Culture Techniques; Cells, Cultured; Female; Fetus; Gestational Age; Heart; Heart Ventricles; Hyperplasia; Hypertrophy; Mitogen-Activated Protein Kinases; Myocardium; Pregnancy; Sheep; Ventricular Function | 2003 |
Angiotensin II phosphorylation of extracellular signal-regulated kinases in rat anterior pituitary cells.
Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; ErbB Receptors; Estrogens; Female; Hyperplasia; Mitogen-Activated Protein Kinases; Phosphorylation; Pituitary Gland, Anterior; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; src-Family Kinases; Type C Phospholipases; Vasoconstrictor Agents | 2003 |
Prevalence and role of a raised aldosterone to renin ratio in the diagnosis of primary aldosteronism: a debate on the scientific logic of the use of the ratio in practice.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Diagnosis, Differential; Diagnostic Tests, Routine; Humans; Hyperaldosteronism; Hyperplasia; Hypertension; Renin | 2003 |
Early pathophysiological changes in cerebral vessels predisposing to stroke.
Topics: Amlodipine; Angiotensin II; Animals; Arterioles; Benzylamines; Brain; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; CREB-Binding Protein; Disease Susceptibility; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation; Hyperplasia; Hypertension; Models, Animal; Muscle, Smooth, Vascular; Nicotine; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nuclear Proteins; Oxidative Stress; Proliferating Cell Nuclear Antigen; Rats; Stroke; Sulfonamides; Trans-Activators | 2003 |
Calcineurin promotes the expression of monocyte chemoattractant protein-1 in vascular myocytes and mediates vascular inflammation.
Topics: Angiotensin II; Animals; Calcineurin; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomyopathy, Hypertrophic; Cells, Cultured; Chemokine CCL2; Cyclosporine; Femoral Artery; Gene Expression Regulation; Humans; Hyperplasia; Imidazoles; Macrophages; MAP Kinase Kinase 6; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Promoter Regions, Genetic; Protein Biosynthesis; Proteins; Pyridines; Rats; Recombinant Fusion Proteins; RNA, Messenger; Signal Transduction; Tetrazoles; Transcription, Genetic; Tunica Intima; Valine; Valsartan; Vasculitis | 2004 |
Tissue angiotensin-converting enzyme in imposed and physiological flow-related arterial remodeling in mice.
Topics: Alleles; Angiotensin II; Animals; Arteries; Carotid Arteries; Female; Hemorheology; Hyperplasia; Hypertrophy; Ligation; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A; Postpartum Period; Pregnancy; Protein Structure, Tertiary; Sequence Deletion; Stress, Mechanical; Uterus | 2004 |
Cyclin-dependent kinase inhibitor, p21Waf1, regulates vascular smooth muscle cell hypertrophy.
Topics: Adenoviridae; Angiotensin II; Animals; Aorta, Thoracic; Blood Proteins; Cell Cycle; Cell Cycle Proteins; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Fetal Proteins; Gene Transfer Techniques; Hyperplasia; Hypertension; Hypertrophy; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Tumor Suppressor Proteins; Vasoconstrictor Agents | 2004 |
Signaling molecules in overcirculation-induced pulmonary hypertension in piglets: effects of sildenafil therapy.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Anastomosis, Surgical; Angiopoietin-1; Angiotensin II; Animals; Arterioles; Bone Morphogenetic Protein Receptors, Type I; Bone Morphogenetic Protein Receptors, Type II; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Evaluation, Preclinical; Endothelin-1; Gene Expression Regulation; Hyperplasia; Hypertension, Pulmonary; Models, Animal; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Protein Serine-Threonine Kinases; Pulmonary Artery; Purines; Random Allocation; Receptors, Growth Factor; RNA, Messenger; Signal Transduction; Sildenafil Citrate; Subclavian Artery; Sulfones; Sus scrofa; Vascular Endothelial Growth Factor A | 2004 |
[Inhibition of hyperplasia of vascular smooth muscle cells in rat by the plasmid containing the short hairpin RNA of angiotensin II type 1 receptor].
Topics: Angiotensin II; Animals; Aorta; Cell Proliferation; Cells, Cultured; Hyperplasia; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Plasmids; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA Interference; RNA, Messenger; RNA, Small Interfering; Transfection | 2004 |
Transforming growth factor-beta1 expression and the role of angiotensin-converting enzyme inhibitor on perianastomotic intimal hyperplasia in polytetrafluoroethylene graft implanted in rabbit carotid artery.
Topics: Anastomosis, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessel Prosthesis Implantation; Captopril; Carotid Artery, Common; Hyperplasia; Polytetrafluoroethylene; Rabbits; RNA, Messenger; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tunica Intima | 2004 |
Effect of chymase inhibition on the arteriovenous fistula stenosis in dogs.
Topics: Acetamides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arteriovenous Shunt, Surgical; Brachial Artery; Chymases; Constriction, Pathologic; Dogs; Hyperplasia; Mast Cells; Protease Inhibitors; Pyrimidines; Receptor, Angiotensin, Type 1; Serine Endopeptidases; Transforming Growth Factor beta; Tunica Intima; Tunica Media; Veins | 2005 |
Heme oxygenase-1 in vascular smooth muscle cells counteracts cardiovascular damage induced by angiotensin II.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensin II; Animals; Blood Pressure; Cardiovascular System; Coronary Vessels; Deoxyguanosine; Dose-Response Relationship, Drug; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hyperplasia; Isoprostanes; Membrane Proteins; Mice; Mice, Transgenic; Muscle, Smooth, Vascular; Myocardium; Myocytes, Cardiac; Myocytes, Smooth Muscle; Oxidative Stress; Sodium Chloride, Dietary; Transduction, Genetic; Tunica Intima; Vasculitis | 2005 |
Interaction between mild hypercholesterolemia, HDL-cholesterol levels, and angiotensin II in intimal hyperplasia in mice.
Topics: Angiotensin II; Animals; Carotid Arteries; Cholesterol, HDL; Diet; Hypercholesterolemia; Hyperplasia; Immunohistochemistry; Lipid Metabolism; Mice; Mice, Inbred C57BL | 2006 |
Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Blood Flow Velocity; C-Reactive Protein; Carotid Arteries; Carotid Stenosis; Diet, Atherogenic; Hemorheology; Hemorrhage; Hyperlipoproteinemia Type II; Hyperplasia; Intercellular Adhesion Molecule-1; Interleukin-6; Lipids; Macrophages; Male; Mice; Mice, Inbred C57BL; Phenotype; Prostheses and Implants; Shear Strength; Stress, Mechanical; Tunica Intima; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2006 |
Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: Potential relevance to vein graft hyperplasia.
Topics: Angiotensin II; Animals; Carotid Arteries; Cell Culture Techniques; Humans; Hyperplasia; Inhibitor of Apoptosis Proteins; Jugular Veins; Kruppel-Like Transcription Factors; Microtubule-Associated Proteins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neoplasm Proteins; Rabbits; RNA, Messenger; Saphenous Vein; Survivin; Tumor Necrosis Factor-alpha; Up-Regulation | 2006 |
A case of ACTH-independent bilateral macronodular adrenal hyperplasia and severe congestive heart failure.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Heart Failure; Humans; Hydrocortisone; Hyperplasia; Male; Middle Aged; Pituitary ACTH Hypersecretion; Receptor, Melanocortin, Type 2 | 2006 |
Forkhead transcription factor FOXO3a is a negative regulator of angiogenic immediate early gene CYR61, leading to inhibition of vascular smooth muscle cell proliferation and neointimal hyperplasia.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Apoptosis; Atherosclerosis; Carotid Artery Injuries; Catheterization; Cell Division; Cells, Cultured; Culture Media; Culture Media, Conditioned; Cysteine-Rich Protein 61; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation; Genes, Reporter; Humans; Hyperplasia; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; Mice; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Transcription, Genetic; Transduction, Genetic; Tunica Intima | 2007 |
Foxing smooth muscle cells: FOXO3a-CYR61 connection.
Topics: Angiotensin II; Animals; Apoptosis; Arteries; Atherosclerosis; Cell Division; Cells, Cultured; Culture Media, Conditioned; Cysteine-Rich Protein 61; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Hyperplasia; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Mice; Muscle Cells; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rats; Recombinant Fusion Proteins; Transcription, Genetic; Tunica Intima | 2007 |
Matrine induces apoptosis in angiotensin II-stimulated hyperplasia of cardiac fibroblasts: effects on Bcl-2/Bax expression and caspase-3 activation.
Topics: Alkaloids; Angiotensin II; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Proliferation; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Enzyme Activation; Fibroblasts; Hyperplasia; In Vitro Techniques; Matrines; Mice; Microscopy, Phase-Contrast; Myocardium; Proto-Oncogene Proteins c-bcl-2; Quinolizines | 2007 |
Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat.
Topics: Angiotensin II; Animals; Fluorobenzenes; Graft Occlusion, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperplasia; Male; Pyrimidines; Random Allocation; Rats; Rats, Wistar; Rosuvastatin Calcium; Stents; Sulfonamides; Tunica Intima | 2008 |
Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Aorta, Abdominal; Blood Pressure; Carotid Arteries; Catheterization; Disease Models, Animal; Heart Rate; Hyperplasia; Hypertension; Imidazoles; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Tunica Intima | 2008 |
[Functional and structural vascular reactions following intermittent administration of angiotensin in spontaneously hypertensive rats].
Topics: Angiotensin II; Animals; Arteries; Blood Pressure; Hyperplasia; Hypertension; Hypertrophy; Male; Rats; Rats, Inbred Strains | 1983 |
Is estrogen-induced pituitary hyperplasia and hyperprolactinaemia mediated by angiotensin II?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cell Division; Diethylstilbestrol; Enalapril; Enalaprilat; Estrogens; Estrogens, Non-Steroidal; Humans; Hyperpituitarism; Hyperplasia; Hyperprolactinemia; Imidazoles; Losartan; Prolactin; Pyridines; Rats; Rats, Inbred F344; Rats, Wistar; Tetrazoles; Tumor Cells, Cultured | 1995 |
Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Benzimidazoles; Biphenyl Compounds; Calcium; Cells, Cultured; Cytosol; Dinoprost; DNA; Fura-2; Hyperplasia; Hypertrophy; Ionomycin; Muscle Proteins; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Tetrazoles | 1994 |
Components of the protein synthesis and folding machinery are induced in vascular smooth muscle cells by hypertrophic and hyperplastic agents. Identification by comparative protein phenotyping and microsequencing.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Blood; Cells, Cultured; Chaperonin 60; HSP70 Heat-Shock Proteins; Hyperplasia; Hypertrophy; Isoenzymes; Isomerases; Male; Molecular Sequence Data; Muscle Proteins; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Protein Disulfide-Isomerases; Rats; Rats, Sprague-Dawley | 1995 |
Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Dose-Response Relationship, Drug; Enalapril; Hyperplasia; Hypertrophy; Imidazoles; Immunosuppressive Agents; Juxtaglomerular Apparatus; Losartan; Macaca mulatta; Pyridines; Renin; Tetrazoles; Time Factors | 1994 |
Hyperplastic growth of aortic smooth muscle cells in renovascular hypertensive rabbits is characterized by the expansion of an immature cell phenotype.
Topics: Actins; Angiotensin II; Animals; Aorta; Blood Pressure; Desmin; Fluorescent Antibody Technique; Gene Expression Regulation; Hyperplasia; Hypertension, Renovascular; Male; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Rabbits; RNA, Messenger; Vimentin | 1994 |
Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.
Topics: Angiotensin II; Angiotensinogen; Animals; Cardiomegaly; Cells, Cultured; Fibroblasts; Gene Expression Regulation; Genes, fos; Hyperplasia; Myocardium; Rats; Receptors, Angiotensin; Transforming Growth Factor beta | 1993 |
Role of transforming growth factor-beta 1 in the cellular growth response to angiotensin II.
Topics: Angiotensin II; Animals; Biological Assay; Cell Division; Cells, Cultured; DNA; Fibroblast Growth Factor 2; Hyperplasia; Hypertrophy; Muscle, Smooth, Vascular; Rats; Rats, Inbred WKY; Transforming Growth Factor beta | 1993 |
Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; Coronary Disease; Graft Rejection; Graft Survival; Heart Transplantation; Hyperplasia; Male; Mice; Mice, Inbred DBA; Myocardium; Tetrazoles; Transplantation, Homologous | 1996 |
Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Endothelium, Vascular; Graft Occlusion, Vascular; Hyperplasia; Imidazoles; Jugular Veins; Microscopy, Electron, Scanning; Muscle Contraction; Muscle, Smooth, Vascular; Rabbits; Receptors, Angiotensin; Tetrazoles; Tunica Intima | 1996 |
Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts.
Topics: Angiotensin II; Animals; Calcium; Cell Communication; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Fibroblasts; Fibronectins; Fibrosis; Flow Cytometry; Gene Expression Regulation; Hyperplasia; Hypertrophy; Imidazoles; Kidney; Protein Kinase C; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Receptors, Angiotensin; RNA, Messenger; Transforming Growth Factor beta; Up-Regulation | 1997 |
Effect of taurine on angiotensin II-induced hypertrophy of neonatal rat cardiac cells.
Topics: Angiotensin II; Animals; Animals, Newborn; Genes, Immediate-Early; Heart; Hyperplasia; Hypertrophy; Myocardium; Rats; Rats, Wistar; Taurine | 1997 |
Angiotensin II-induced Ca2+ mobilization and prolactin release in normal and hyperplastic pituitary cells.
Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; DNA Replication; Estrogens; Female; Hyperplasia; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Rats, Sprague-Dawley; Thymidine | 1998 |
Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1.
Topics: Angiotensin II; Blotting, Northern; Bronchi; Cells, Cultured; DNA-Binding Proteins; Early Growth Response Protein 1; Humans; Hyperplasia; Hypertrophy; Immediate-Early Proteins; Immunohistochemistry; Muscle, Smooth; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; RNA, Messenger; Time Factors; Transcription Factors; Transforming Growth Factor beta | 1998 |
Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Carotid Arteries; Cell Division; Data Interpretation, Statistical; DNA Replication; Hydralazine; Hyperplasia; Hypertrophy; In Vitro Techniques; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley | 1998 |
Differential regulation of p27kip1 levels and CDK activities by hypertrophic and hyperplastic agents in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Becaplermin; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cells, Cultured; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; DNA; G1 Phase; Hyperplasia; Hypertrophy; Microtubule-Associated Proteins; Muscle, Smooth, Vascular; Phosphorylation; Platelet-Derived Growth Factor; Protein Biosynthesis; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-sis; Rats; Retinoblastoma Protein; S Phase; Signal Transduction; Tumor Suppressor Proteins | 1999 |
Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aspartic Acid Endopeptidases; Benzimidazoles; Biphenyl Compounds; Cathepsin D; Cathepsin E; Cell Division; Cells, Cultured; Culture Media, Conditioned; Hyperplasia; Hypertension; Hypertrophy; Indans; Kallikreins; Male; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Tissue Kallikreins | 1999 |
Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arteriosclerosis; Carotid Artery Injuries; Carotid Artery, Common; Catheterization; Cell Division; Cell Movement; Cells, Cultured; Glycine; Hyperplasia; Male; Mitogen-Activated Protein Kinase 1; Muscle, Smooth, Vascular; Protein Kinase C; Proto-Oncogene Proteins p21(ras); Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Tetrazoles | 1999 |
Calcium influx and intracellular stores in angiotensin II stimulation of normal and hyperplastic pituitary cells.
Topics: Angiotensin II; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Female; Hyperplasia; Inositol 1,4,5-Trisphosphate; Intracellular Membranes; Pituitary Gland; Potassium; Rats; Rats, Sprague-Dawley; Reference Values; Thapsigargin | 1999 |
Angiotensin II stimulates proliferation of adventitial fibroblasts cultured from rat aortic explants.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Blotting, Northern; Cell Division; Cells, Cultured; DNA; Fibroblasts; Gene Expression; Genes, Immediate-Early; Growth Substances; Hyperplasia; Losartan; Male; Proto-Oncogenes; Rats; Rats, Sprague-Dawley; RNA | 1999 |
Involvement of calcineurin in angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibroblast hyperplasia of rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Calcineurin Inhibitors; Calcium; Cardiomegaly; Cell Division; Cells, Cultured; Cyclosporine; DNA; Fibroblasts; Fura-2; Hyperplasia; Losartan; Myocardium; Protein Kinase C; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Signal Transduction | 1999 |
Bromocriptine restores angiotensin II response in pituitary hyperplasia.
Topics: Angiotensin II; Animals; Bromocriptine; Calcium; Calcium Channels; Diethylstilbestrol; Female; Hyperplasia; Immunohistochemistry; In Vitro Techniques; Pituitary Gland; Potassium; Prolactin; Rats; Rats, Sprague-Dawley; Thapsigargin | 2000 |
Angiotensin II receptor antagonist, L-158,809, prevents intimal hyperplasia in dog grafted veins.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Dogs; Hyperplasia; Imidazoles; In Vitro Techniques; Placebos; Receptors, Angiotensin; Tetrazoles; Tunica Intima; Veins | 2000 |
Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Glomerulonephritis; Hyperplasia; Kidney Transplantation; Lisinopril; Male; Oligopeptides; Postoperative Complications; Postoperative Period; Proteinuria; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Artery; Renin-Angiotensin System; Tunica Intima | 2001 |
Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Arginine Vasopressin; Cushing Syndrome; Diagnosis, Differential; Humans; Hydrocortisone; Hyperplasia; Male; Middle Aged; Posture; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tomography, X-Ray Computed | 2001 |
Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma.
Topics: Angiotensin II; Breast; Breast Neoplasms; Carcinoma in Situ; Cell Division; Dose-Response Relationship, Drug; Female; Fluorescent Antibody Technique; Humans; Hyperplasia; Immunohistochemistry; In Situ Hybridization; Neoplasm Invasiveness; Proliferating Cell Nuclear Antigen; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation | 2001 |
[The role of cyclin-dependent kinase inhibitors in hyperplasia and hypertrophy of vascular smooth muscle cells].
Topics: Angiotensin II; Animals; Becaplermin; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinase Inhibitor p57; Cyclins; Disease Models, Animal; Gene Expression; Hyperplasia; Hypertrophy; Male; Muscle, Smooth, Vascular; Nuclear Proteins; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Tumor Suppressor Proteins | 2001 |
Functional significance of activation of calcium/calmodulin-dependent protein kinase II in angiotensin II--induced vascular hyperplasia and hypertension.
Topics: Angiotensin II; Animals; Blood Vessels; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cell Cycle; Disease Models, Animal; DNA; Enzyme Activation; Hyperplasia; Hypertension; Male; Norepinephrine; Phosphorylation; Rabbits; Rats; Rats, Sprague-Dawley | 2002 |
Effects of all-trans retinoic acid on angiotensin II-induced myocyte hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Calcium; Cardiomegaly; Cell Count; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Fibroblasts; Golgi Apparatus; Hyperplasia; Intracellular Fluid; Myocardium; Proteins; Rats; Rats, Wistar; Sarcomeres; Tretinoin | 2002 |
Hyperglycemia enhances VSMC proliferation with NF-kappaB activation by angiotensin II and E2F-1 augmentation by growth factors.
Topics: Angiotensin II; Animals; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Division; Cells, Cultured; DNA; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; Fetal Blood; Gene Expression Regulation; Glucose; Growth Substances; Hyperglycemia; Hyperplasia; Male; Muscle, Smooth, Vascular; NF-kappa B; Promoter Regions, Genetic; Protein Binding; Rats; Rats, Sprague-Dawley; Transcription Factor RelA; Transcription Factors; Transcription, Genetic | 2002 |
Failure of saralasin to predict a response to surgery in renovascular hypertension.
Topics: Adult; Angiography; Angiotensin II; Blood Pressure; Blood Pressure Determination; Evaluation Studies as Topic; Female; Humans; Hyperplasia; Hypertension, Renal; Kidney; Kidney Transplantation; Male; Prognosis; Renal Artery; Renal Veins; Renin; Saralasin; Transplantation, Autologous | 1977 |
Bartter's syndrome.
Topics: Angiotensin II; Bartter Syndrome; Humans; Hyperaldosteronism; Hyperplasia; Hypokalemia; Juxtaglomerular Apparatus; Kidney Glomerulus; Kidney Tubules; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; Renin | 1977 |
Plasma renin activity and urinary aldosterone in Cushing's syndrome.
Topics: Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Child; Corticosterone; Cushing Syndrome; Desoxycorticosterone; Dexamethasone; Female; Furosemide; Humans; Hyperplasia; Male; Middle Aged; Posture; Renin | 1978 |
[Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
Topics: Angiotensin II; Blood Pressure; Humans; Hyperplasia; Hypertension, Renal; Kidney; Kidney Diseases; Regional Blood Flow; Renal Artery Obstruction; Renal Veins; Renin; Saralasin | 1977 |
[Morphologic studies of the juxtaglomerular apparatus of the rat treated with furosemide].
Topics: Angiotensin II; Animals; Furosemide; Hyperplasia; Hypertrophy; Juxtaglomerular Apparatus; Kidney; Rats; Renin | 1977 |
Role of angiotensin subtype 2 receptor in neointima formation after vascular injury.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Carotid Arteries; Carotid Artery Injuries; Catheterization; Hyperplasia; Imidazoles; Indoles; Losartan; Male; Oligopeptides; Perindopril; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles; Tunica Intima | 1992 |
Inhibition of injury induced intimal hyperplasia by saralasin in rats.
Topics: Angiotensin II; Animals; Aorta; Hyperplasia; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Saralasin | 1992 |
Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.
Topics: Angiotensin II; Animals; Cell Division; Cells, Cultured; DNA Replication; Gene Expression; Hyperplasia; Hypertrophy; In Vitro Techniques; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; RNA, Messenger; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta | 1992 |
Water deprivation stimulates transforming growth factor-beta 2 accumulation in the juxtaglomerular apparatus of mouse kidney.
Topics: Angiotensin II; Animals; Dehydration; Female; Hyperplasia; Juxtaglomerular Apparatus; Mice; Renin; Transforming Growth Factor beta | 1991 |
Effect of captopril on aldosterone response to potassium infusion in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Angiotensin II; Captopril; Female; Flame Ionization; Humans; Hyperaldosteronism; Hyperplasia; Infusions, Intravenous; Male; Middle Aged; Potassium; Potassium Chloride; Radioimmunoassay; Renin | 1991 |
Differential regulation of Na+/H+ antiporter gene expression in vascular smooth muscle cells by hypertrophic and hyperplastic stimuli.
Topics: Angiotensin II; Animals; Blood; Carrier Proteins; Cell Division; Fibroblast Growth Factors; Gene Expression Regulation; Hyperplasia; Hypertrophy; Kinetics; Male; Mitogens; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Protons; Rats; Rats, Inbred Strains; RNA, Messenger; Sodium; Sodium-Hydrogen Exchangers | 1990 |
Hypertrophy and hyperplasia cause differing effects on vascular smooth muscle cell Na+/H+ exchange and intracellular pH.
Topics: Amiloride; Angiotensin II; Animals; Aorta, Thoracic; Blood; Cell Division; Hydrogen-Ion Concentration; Hyperplasia; Hypertrophy; Kinetics; Male; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Protein Kinase C; Protons; Rats; Rats, Inbred Strains; Sodium | 1990 |
Ultrastructural juxtaglomerular cell changes in normotensive rats treated with quinapril, an inhibitor of angiotensin-converting enzyme.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Hyperplasia; Hypertrophy; Isoquinolines; Juxtaglomerular Apparatus; Quinapril; Rats; Rats, Inbred Strains; Tetrahydroisoquinolines | 1990 |
In vitro studies in primary aldosteronism: baseline steroid production and aldosterone responses to ACTH and angiotensin II.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Corticosterone; Female; Humans; Hydrocortisone; Hyperaldosteronism; Hyperplasia; Male | 1988 |
Cortisol responsiveness to insulin-induced hypoglycemia in Cushing's syndrome with huge nodular adrenocortical hyperplasia.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Angiotensin II; Arginine Vasopressin; Circadian Rhythm; Cushing Syndrome; Epinephrine; Humans; Hydrocortisone; Hyperplasia; Hypoglycemia; Insulin; Male; Metyrapone; Middle Aged; Norepinephrine; Pituitary-Adrenal Function Tests | 1986 |
[Bartter syndrome. Vascular angiotensin II resistance with juxtaglomerular cellular hyperplasia and hyperaldosteronism].
Topics: Adult; Angiotensin II; Humans; Hyperaldosteronism; Hyperplasia; Hypokalemia; Kidney Diseases; Potassium; Spironolactone | 1965 |
Hypokalaemic alkalosis and hyperplasia of the juxtaglomerular apparatus without hypertension or oedema.
Topics: Adolescent; Alkalosis; Angiotensin II; Blood Pressure; Extracellular Space; Humans; Hyperaldosteronism; Hyperplasia; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Male; Potassium; Renin; Sodium; Spironolactone | 1967 |
Hyperplasia of the juxtaglomerular complex with secondary aldosteronism without hypertension (Bartter's syndrome).
Topics: 17-Ketosteroids; Adrenocorticotropic Hormone; Aldosterone; Ammonium Chloride; Angiotensin II; Bicarbonates; Body Height; Body Weight; Catecholamines; Child; Chlorides; Diet; Female; Glucose Tolerance Test; Humans; Hyperaldosteronism; Hyperplasia; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Function Tests; Metyrapone; Microscopy, Electron; Muscles; Norepinephrine; Pituitary-Adrenal Function Tests; Potassium; Renin; Serum Albumin; Sodium; Spironolactone; Triamterene; Water-Electrolyte Balance | 1968 |
Adrenalectomy in cases of severe renal sclerosis.
Topics: Adrenal Glands; Adrenal Medulla; Adrenalectomy; Angiotensin II; Glomerulonephritis; Histocytochemistry; Humans; Hyperplasia; Hypertension, Renal; Kidney Glomerulus; Nephrosclerosis; Organ Size; Pyelonephritis | 1969 |
A case of Bartter's syndrome with abnormal renin response to salt load.
Topics: Adrenal Gland Diseases; Aldosterone; Alkalosis; Angiotensin II; Blood Pressure; Child; Diet; Dwarfism; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Norepinephrine; Potassium; Renin; Sodium Chloride | 1969 |
Plasma renin in Bartter's syndrome: response of depression of stimuli for renin release.
Topics: Adrenal Gland Diseases; Alkalosis; Angiotensin II; Child; Growth Disorders; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Renin | 1969 |
[Bartter's syndrome--case report and literature review].
Topics: Adrenal Gland Diseases; Adult; Alkalosis; Angiotensin II; Blood Pressure; Familial Mediterranean Fever; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney; Male; Paralysis; Renin; Tetany | 1969 |
A sibship with Bartter's syndrome: failure of total adrenalectomy to correct the potassium wasting.
Topics: Adrenal Gland Diseases; Adrenalectomy; Aldosterone; Alkalosis; Angiotensin II; Child, Preschool; Erythrocytes; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Hyponatremia; Infant; Juxtaglomerular Apparatus; Kidney; Male; Potassium; Renin; Sodium | 1969 |
Pathogenesis of Bartter's syndrome.
Topics: Adrenal Gland Diseases; Adrenocorticotropic Hormone; Albumins; Aldosterone; Alkalosis; Angiotensin II; Aniline Compounds; Anticonvulsants; Child; Dexamethasone; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney; Norepinephrine; Potassium; Potassium Chloride; Pyridones; Renin; Secretory Rate; Sodium; Spironolactone | 1969 |
So-called Bartter's syndrome.
Topics: Adrenal Gland Diseases; Albumins; Alkalosis; Angiotensin II; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Juxtaglomerular Apparatus; Renin; Sodium | 1969 |
[Changes of the pressoactive substance extractable from both kidneys of rats with hypertension induced by complete ligation of the aorta between the renal arteries].
Topics: Angiotensin II; Animals; Hyperplasia; Hypertension, Renal; Ischemia; Kidney; Kidney Diseases; Rats; Renin | 1968 |
Bartter's syndrome. A report of four cases, including three in one sibship, with comparative histologic evaluation of the juxtaglomerular apparatuses and glomeruli.
Topics: Alkalosis; Angiotensin II; Blood Pressure; Carbon Dioxide; Cerebrospinal Fluid Proteins; Electrolytes; Female; Glycosuria; Humans; Hydrogen-Ion Concentration; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Infant; Infant, Newborn; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Glomerulus; Magnesium; Male; Microscopy; Microscopy, Electron; Phosphorus; Proteinuria; Specific Gravity; Spironolactone | 1970 |
An unusual type of hypokalaemic alkalosis with a disturbance of renin and aldosterone.
Topics: Adolescent; Adrenal Cortex Hormones; Albumins; Aldosterone; Alkalosis; Angiotensin II; Creatinine; Diet, Sodium-Restricted; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Kidney Diseases; Male; Potassium; Renin; Spironolactone; Triamterene | 1970 |
Case studies of siblings with juxtaglomerular hyperplasia and secondary aldosteronism associated with severe azotemia and renal rickets--Bartter's syndrome or disease?
Topics: Aldosterone; Alkalosis; Angiotensin II; Bone Diseases; Child; Child, Preschool; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Glomerulus; Male; Spironolactone; Triamterene; Valine | 1970 |
A case of Bartter's syndrome with surgical treatment followed for four years.
Topics: Adrenalectomy; Adult; Alkalosis; Angiotensin II; Epinephrine; Follow-Up Studies; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Male; Renin | 1971 |
Determination of plasma renin concentration by angiotensin I immunoassay. Diagnotic import of precise measurement of subnormal renin in hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Hyperfunction; Aldosterone; Angiotensin II; Animals; Desoxycorticosterone; Humans; Hyperaldosteronism; Hyperplasia; Hypertension; Immunoassay; Iodine Radioisotopes; Methods; Renin; Sheep | 1971 |
[Angiotensin resistence and hyperaldosteronism with normal blood pressure].
Topics: Adult; Alkalosis; Angiotensin II; Blood Pressure; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases | 1967 |
Bartter's syndrome. A manifestation of renal tubular defects.
Topics: Adult; Aldosterone; Alkalosis; Angiotensin II; Bicarbonates; Chlorides; Diet Therapy; Diet, Sodium-Restricted; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Male; Potassium; Renin; Sodium; Sodium Chloride | 1972 |
[Angiotensin resistance. Critical remarks on the so called Bartter syndrome].
Topics: Adult; Aged; Alkalosis; Angiotensin II; Blood Pressure; Blood Pressure Determination; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Norepinephrine; Photometry; Potassium; Potassium Chloride | 1971 |
[The Bartter syndrome and the pseudo-Bartter syndrome].
Topics: Adult; Alkalosis; Angiotensin II; Biopsy; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Male; Middle Aged; Renin; Sodium Chloride; Syndrome | 1972 |
A study of the inhibition of the renin-angiotensin system in renal potassium wasting syndromes, including Bartter's syndrome.
Topics: Adolescent; Alkalosis; Angiotensin II; Calcium; Child; Child, Preschool; Cystinosis; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Hypophosphatemia, Familial; Juxtaglomerular Apparatus; Kidney Diseases; Male; Potassium; Proteinuria; Renin; Syndrome | 1972 |
Primary aldosteronism due to hyperplasia of zona glomerulosa: failure of suppression by DOCA or stimulation by angiotensin.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Hyperfunction; Angiotensin II; Desoxycorticosterone; Glucose Tolerance Test; Humans; Hyperaldosteronism; Hyperplasia; Hypertension; Prognosis; Stimulation, Chemical | 1972 |
Studies on the site of renal salt loss in a patient with Bartter's syndrome.
Topics: Adolescent; Adult; Alkalosis; Angiotensin II; Biological Transport, Active; Blood Pressure; Child; Child, Preschool; Chlorothiazide; Glomerular Filtration Rate; Growth Disorders; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Inulin; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Function Tests; Kidney Tubules, Distal; Loop of Henle; Male; Natriuresis; Sodium; Syndrome | 1973 |
Six year follow-up of a child with Bartter syndrome.
Topics: Aldosterone; Alkalosis; Angiotensin II; Biopsy; Blood Pressure; Child, Preschool; Diet Therapy; Female; Follow-Up Studies; Growth Disorders; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Concentrating Ability; Kidney Diseases; Norepinephrine; Potassium; Renin; Secretory Rate; Sodium Chloride; Spironolactone; Syndrome; Vasopressins | 1973 |
Some observations on the pathogenesis of Bartter's syndrome.
Topics: Adult; Aldosterone; Alkalosis; Angiotensin II; Blood Volume; Drug Therapy, Combination; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney; Kidney Diseases; Male; Potassium; Propranolol; Renin; Spironolactone | 1973 |
Bartter's syndrome and erythrocytosis.
Topics: Adult; Alkalosis; Angiotensin II; Blood Cell Count; Blood Pressure; Erythrocytes; Erythropoiesis; Hematocrit; Hemoglobinometry; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Iron; Juxtaglomerular Apparatus; Kidney Diseases; Male; Polycythemia; Potassium; Renin; Reticulocytes; Sodium; Syndrome | 1973 |